Texas Advance Directives Act: a Threat to Catholic Identity?

Total Page:16

File Type:pdf, Size:1020Kb

Texas Advance Directives Act: a Threat to Catholic Identity? FEATURE ARTICLE The Texas Advance Directives Act: A Threat to Catholic Identity? objection, unless another facility is willing Elliott Louis Bedford to accept the transfer of the patient. Graduate Assistant, Ascension Health Graduate Student, Health Care Ethics, This legal protection granted to physicians Saint Louis University requesting to unilaterally withhold LST St. Louis, Mo. despite a family’s objection raises the [email protected] question whether such a law poses a threat to the identity of Catholic hospitals. Most Introduction immediately, it raises concerns with regard to observance of the Ethical and Religious Medical “futility” cases have generated Directives for Catholic Health Care Services controversy among medical professionals, (ERDs). Applicable directives include bioethicists, legal professionals and the Directive 57 since a physician can decide public for decades due to widespread to withhold treatment from a patient if it disagreement about the point at which a is deemed medically inappropriate, medical intervention is no longer Directive 58 because it allows physicians considered beneficial to a critically ill to withhold artificial nutrition and patient. To date, no uniform method has hydration, and Directive 60 which been established to resolve these cases. prohibits euthanasia. Moreover, even if This has prompted the enactment of laws the TADA does not threaten Catholic including the Texas Advance Directives identity with regard to these directives, it Act of 1999 (TADA). The TADA raises concerns whether it threatens a establishes a process for discerning the Catholic institution’s commitment to appropriateness of a physician’s request to provide high quality end-of-life care to withhold life-sustaining treatment (LST), suffering and vulnerable patients and despite the patient’s pre-existing advanced families. To address these concerns it is directive. This process includes a necessary to review data collected from consultation between the patient’s family health care institutions that have made use and an ethical/medical review committee of the process. An analysis of recent review to analyze the patient’s medical record and studies lends insight into the effects of the determine whether the LST in question is TADA on cases of medically inappropriate medically inappropriate. If the treatment treatments, and will help evaluate the is deemed inappropriate, the physician is potential impact of these laws on Catholic afforded legal safe-harbor to unilaterally hospitals. withhold LST after a minimum ten-day waiting period, despite the family’s Copyright © 2012 CHA. Permission granted to CHA-member organizations and Saint Louis University to copy and distribute for educational purposes. 2 FEATURE ARTICLE Does the TADA Violate the ERDs? Contentious medical “futility” cases However, this argument is flawed as it including that of Emilio Lee Gonzales, a misinterprets the directive. Directive 57 16-month-old pediatric patient suffering morally justifies a patient’s decision to from a fatal neurological condition known refuse a given treatment based on the as Leigh’s disease, have raised questions principle that they themselves have judged regarding the law’s compliance with the the benefits associated with the treatment church’s moral tradition, articulated in to be insufficient or the burdens to be part by the ERDs, in the context of end- excessive. A true violation of Directive 57 of-life decision making.1 The tradition would occur if a physician imposed a teaches that individuals have a duty to treatment on a patient, who has judged it preserve their life, but not by any means extraordinary, because the physician has necessary. In 1957, Pope Pius XII deemed it ordinary. As mentioned, attempted to clarify that individuals have Directive 57 morally justifies a patient’s an obligation to preserve their life by ability to refuse a treatment in instances in ordinary means, “that is to say, means that which it provides insufficient benefit or do not involve a grave burden for oneself excessive burdens or harm. Therefore, in or another.”2 This obligation does not its application, this directive assumes that extend to the use of extraordinary or a treatment is offered to the patient. It disproportionate means. Directive 57 does not authorize a patient to request a represents this teaching of Pius XII, treatment, either ordinary or stating: extraordinary. A person may forgo extraordinary or Others may also argue that under the disproportionate means of preserving provisions of Directives 56 and 57, life. Disproportionate means are those physicians have an obligation to honor a that in the patient’s judgment do not patient’s request for treatments, especially offer a reasonable hope of benefit or those that the patient considers ordinary.4 entail an excessive burden, or impose However, neither directive speaks to the excessive expense on the family or the physician’s duty to offer a treatment. community.3 Since the Catholic tradition supports the physician’s ability to conscientiously Given the significance that Directive 57 object in certain circumstances, the places on the patient’s ability to determine tradition does generally recognize that the whether a treatment is ordinary or duty to offer treatment is not absolute.5 extraordinary, it may appear that the Yet, under the TADA the physician’s TADA violates this directive because it ability to refuse is clearly limited. Recent allows physicians to withhold LST from a studies in Critical Care Medicine and the patient based on an external extraordinary Journal of Perinatology report that the means judgment. Copyright © 2012 CHA. Permission granted to CHA-member organizations and Saint Louis University to copy and distribute for educational purposes. 3 FEATURE ARTICLE review committee disagreed with the physiologic ends (e.g. when they are not physician in 30 percent and one-third of being assimilated) or when the artificial cases, respectively.6 In the case that the means (e.g. surgery, tube, maintenance) committee disagrees with the physician’s used to administer the nutrition and judgment, the law specifies that the hydration have become harmful to the physician must continue to provide patient. treatment. Therefore, the comprehensive review process can be understood, in part, Given the controversy concerning the as a means of determining the duty of the provision of MANH in Catholic health physician to provide LST or, rather, the care, its status under the TADA is a threshold at which a physician can particularly sensitive issue.9 Some critics legitimately refuse. In essence, this law may hold that this law enables institutions enables physicians to practice to withhold MANH from a patient even if conscientiously in cases in which it is the only LST being provided.10 This treatment is medically inappropriate and would entail: (1) the physician judging the even harmful. Therefore, it seems the treatment to be medically inappropriate; TADA does not violate Directive 57 (2) the committee agreeing with the because the directive speaks only to the physician’s judgment; (3) no other patient’s ability to refuse treatment, not medical institution is willing to accept request it. Thus, the TADA allows transfer; and (4) the family hasn’t filed or physicians the limited ability to refuse to received a court-ordered injunction. provide treatment, not because they can Further, actual practices involved with judge means to be extraordinary, but implementing the TADA guard against because they have, in principle, a limited this scenario. The patients in cases that duty to offer or provide treatments to appeal to the TADA process are typically patients. admitted in the intensive care unit of the hospital, have multiple co-morbidities, While Directive 57 does not speak to the and are considered to be imminently physician’s duty to provide treatment, the dying.11 In one pediatrics study, all but same cannot be said for Directive 58.7 one patient was ventilator dependent, all Though there has been considerable had do not resuscitate orders, were debate over the proper interpretation of receiving MANH and suffered from a the language used in the directive, it seems range of devastating that, at a minimum, Directive 58 conditions.12 Interestingly, the one patient establishes that medically assisted who was not ventilator dependent but nutrition and hydration (MANH) need received MANH, a patient who suffered not be provided in all circumstances.8 This from severe hypoxic ischemic is especially true when it is objectively encephalopathy, aspiration pneumonia, discernible that nutrition and and seizure disorder, was transferred to hydration are not achieving their another facility on day eight of ten for a Copyright © 2012 CHA. Permission granted to CHA-member organizations and Saint Louis University to copy and distribute for educational purposes. 4 FEATURE ARTICLE tracheotomy and was discharged home.13 Some individuals fear that the TADA will However, given the uniformly severe legally protect physicians in cases of condition of the patients reported in these passive euthanasia, even though the law studies, in addition to the multiple forbids it.16 Euthanasia, an act or omission decision points within the process, data intended to alleviate a patient’s suffering suggest that the process is not invoked or through death, is always forbidden in carried to conclusion in order to simply Catholic hospitals under Directive 60.17 remove MANH. Nonetheless, there is a significant moral difference between removal of Rather, it seems physicians are willing to inappropriate and harmful medical provide MANH to patients even if the treatments and euthanasia. First, there purpose for doing so is primarily for the exists a difference of intention. One seeks benefit of the family. For instance, one to relieve suffering through the study notes that, “Although nutrition and discontinuation of inappropriate and hydration are not obligatory when death is harmful treatment and the other seeks to imminent, they may be made available in relieve suffering through death. Second, amounts carefully adapted to the patient’s there is a difference in causation.
Recommended publications
  • A Catalogue of the Fellows, Candidates, Licentiates [And Extra
    MDCCCXXXVI. / Od- CATALOGUE OF THE FELLOWS, CANDIDATES, AND LICENTIATES, OF THE ftogal College of LONDON. STREET. PRINTED 1!Y G. WGOUFAM., ANGEL COURT, SKINNER A CATALOGUE OF THE FELLOWS, CANDIDATES, AND LICENTIATES, OF THE Ittojjal College of ^ijpstrtans, LONDON. FELLOWS. Sir Henry Halford, Bart., M.D., G.C.IL, President, Physician to their Majesties , Curzon-street . Devereux Mytton, M.D., Garth . John Latham, M.D., Bradwall-hall, Cheshire. Edward Roberts, M.D. George Paulet Morris, M.D., Prince s-court, St. James s-park. William Heberden, M.D., Elect, Pall Mall. Algernon Frampton, M.D., Elect, New Broad- street. Devey Fearon, M.D. Samuel Holland, M.D. James Franck, M.D., Bertford-street. Park- lane. Sir George Smith Gibbes, Knt., M.D. William Lambe, M.D., Elect, Kings-road, Bedford-row. John Johnstone, M.D., Birmingham. Sir James Fellowes, Knt., M.D., Brighton. Charles Price, M.D., Brighton. a 2 . 4 Thomas Turner, M.D., Elect, and Trea- Extraordinary to surer, Physician the Queen , Curzon-street Edward Nathaniel Bancroft, M.D., Jamaica. Charles Dalston Nevinson, M.D., Montagu- square. Robert Bree, M.D., Elect, Park-square , Regent’s-park. John Cooke, M.D., Gower-street Sir Arthur Brooke Faulkner, Knt., M.D., Cheltenham. Thomas Hume, M.D., Elect, South-street , Grosvenor-square. Peter Rainier, M.D., Albany. Tristram Whitter, M.D. Clement Hue, M.D., Elect, Guildford- street. John Bright, M.D., Manchester-square. James Cholmeley, M.D., Bridge-street Henry , Blackfriars. Sir Thomas Charles Morgan, Knt., M.D., Dublin. Richard Simmons, M.D. Joseph Ager, M.D., Great Portland-st.
    [Show full text]
  • Transactions
    M,EDICO - CHIRURGICAL TRANSACTIONS, PIUBLISHED BY THE ROYAL MEDICAL AND CHIRURGICAL SOCIETY OF It{en LONDON. VOLUME THE THIRTY-FIRST. LONDON: PRINTED FOR LONGMAN, BROWN, GREEN, AND LONGMANS, PATERNOSTER-ROW. 1848. RICtARDIOUERT , AILNTER, GREE.N ARtIlUB CO1URT, OLD IBAILEY, LOqDON. MEDICO - CHIRURGICAI TRANSACTIONS, PUBLISHED BY THE ROYAL MEDICAL AND CHIRURGICAL SOCIETY OF LONDON. SECOND SERIES. VOLUME THE THIRTEENTH. LONDON: PRJNTED POR LONGMAN, BROWN, GREEN AND LONGMANS, PATERNOSTER-ROW. 1848. RICHARD KINDER, PRINTER, GREEN ARHOUR COURT, OLD BAILEY, LONDON. ROYAL MEDICAL AND CHIRURGICAL SOCIETY OF LONDON. PATRON, THE QUEEN. OFFICERS AND COUNCIL, ELECTED MARCH 1, 1848. PRESIDENT. JAMES MONCRIEFF ARNOTT, F.R.S. rHENRY DAVIES, M.D. JONATHAN M.D., F.R.S. VICE-PRESIDENTS.<V PEREIRA, GEORGE MACILWAIN. LRICHARD PARTRIDGE, F.R.S. { BENJAMIN GUY BABINGTON, M.D., F.R.S. TREASURERS. BENJAMIN PHILLIPS, F.R.S. f WILLIAM BALY, M.D., F.R.S. SECRETARIES. FRED. LE GROS CLARK. { JOHN HENNEN, M.D. LIBRARIANS. l_RICHARD QUAIN, F.R.S. JAMES ALDERSON, M.D., F.R.S. THOMAS MAYO, M.D., F.R.S. ROBERT NAIRNE, M.D. WILLIAM SHARPEY, M.D., F.R.S. OTHER MEMBERS LEONARD STEWART, M.D. OF THE COUNCIL. HENRY ANCELL RICHARD BLAGDEN. GEORGE BUSK. JOHN DALRYMPLE. JAMES PAGET. TRUSTEES OF THE SOCIETY. JAMES M. ARNOTT, F.R.S. JOHN CLENDINNING, M.D., F.R.S. EDWARD STANLEY, F.R.S. a2 FELLOWS OF THE SOCIETY APPOINTED BY THE COUNCIL AS REFEREES OF PAPERS, FOR THE SESSION OF 1847-8. BABINGTON, BENJAMIN G., M.D., F.R.S. BOWMAN, WILLIAM, F.RIS. BUDD, GEORGE, M.D., F.R.S.
    [Show full text]
  • Chipman Family a Genealogy Of
    THE CHIPMAN FAMILY A GENEALOGY OF THE CHIPMANS IN AMERICA 1631-1920 BY BERT LEE CHIPMAN BERT L. CHIPMAN. PUBLISHER WINSTON-SALEM. N. C. COPYRIGHT 1920 BERT L. CHIPMAN MONOTYPED BY THE WINSTON PRINTING COMPANY WrN9TON-SALEM, N. C, Introduction Many hours have been spent in gathering and compiling the data that makes up this genealogy of the Chipman family; a correspondence has been carried on extending to every part of the United States and Canada, requiring several thousand letters; but it has been a pleasant task. What is proposed by genealogical research is not to laud individuals, nor to glorify such families as would other­ wise remain without glory. Heraldic arms have as little worth as military aside from the worth of those bearing them. Not the armor but the army merits and should best repay describing. It has been my earnest desire to make this work as complete and accurate as possible. In this connection I wish to acknowledge the valuable aid in research work rendered by Mr. W. A. Chipman (1788), Mr. S. L. Chip­ man (1959), Mrs. B. W. Gillespie (see 753) and Mrs. Margaret T. Reger (see 920). C Orgin THE NAME CHIPMAN is of English otjgin, early existing in various forms such as,-Chipenham, Chippenham, Chiepman and Chipnam. The name is to be found quite frequently in the books prepared by the Record Commis­ sion appointed by the British Parliament, and from i085 to 1350 it usually appears with the prefix de, as,~e Chippenham. Several towns in England bear the name in one of its f onns, for instance: Chippenham, Buckingham Co., twenty-two miles from London, is "a Liberty in the Parish and Hundred of Burnham, forming a part of the ancient demesnes of the crown and said to be the site of a palace of the Mercian kings." Chippenham, Cambridge Co., sixty-one miles from London, is '' a Parish in the Hundred of Staplehou, a dis­ charged Vicarage in the Archdeaconry of Suffolk and Diocese of Norwich." Chippenham, Wilts Co., ninety-three miles from London, is "a Borough, Market-town and Parish in the Hundred of Chippenham and a place of great antiquity.
    [Show full text]
  • Subject Categories
    Subject Categories Click on a Subject Category below: Anthropology Archaeology Astronomy and Astrophysics Atmospheric Sciences and Oceanography Biochemistry and Molecular Biology Business and Finance Cellular and Developmental Biology and Genetics Chemistry Communications, Journalism, Editing, and Publishing Computer Sciences and Technology Economics Educational, Scientific, Cultural, and Philanthropic Administration (Nongovernmental) Engineering and Technology Geology and Mineralogy Geophysics, Geography, and Other Earth Sciences History Law and Jurisprudence Literary Scholarship and Criticism and Language Literature (Creative Writing) Mathematics and Statistics Medicine and Health Microbiology and Immunology Natural History and Ecology; Evolutionary and Population Biology Neurosciences, Cognitive Sciences, and Behavioral Biology Performing Arts and Music – Criticism and Practice Philosophy Physics Physiology and Pharmacology Plant Sciences Political Science / International Relations Psychology / Education Public Affairs, Administration, and Policy (Governmental and Intergovernmental) Sociology / Demography Theology and Ministerial Practice Visual Arts, Art History, and Architecture Zoology Subject Categories of the American Academy of Arts & Sciences, 1780–2019 Das, Veena Gellner, Ernest Andre Leach, Edmund Ronald Anthropology Davis, Allison (William Gluckman, Max (Herman Leakey, Mary Douglas Allison) Max) Nicol Adams, Robert Descola, Philippe Goddard, Pliny Earle Leakey, Richard Erskine McCormick DeVore, Irven (Boyd Goodenough, Ward Hunt Frere Adler-Lomnitz, Larissa Irven) Goody, John Rankine Lee, Richard Borshay Appadurai, Arjun Dillehay, Tom D. Grayson, Donald K. LeVine, Robert Alan Bailey, Frederick George Dixon, Roland Burrage Greenberg, Joseph Levi-Strauss, Claude Barth, Fredrik Dodge, Ernest Stanley Harold Levy, Robert Isaac Bateson, Gregory Donnan, Christopher B. Greenhouse, Carol J. Levy, Thomas Evan Beall, Cynthia M. Douglas, Mary Margaret Grove, David C. Lewis, Oscar Benedict, Ruth Fulton Du Bois, Cora Alice Gumperz, John J.
    [Show full text]
  • 2018 Program May 21-24, 2018 | Pittsburgh, Pa Pathologyinformatics.Org
    DIGITAL PATHOLOGY REALIZED 2018 PROGRAM MAY 21-24, 2018 | PITTSBURGH, PA PATHOLOGYINFORMATICS.ORG Brought to you by the Association for Pathology Informatics. Greetings and welcome to all of you. Thank you for joining us! The Pathology Informatics Summit 2018 is the 28th sequential year of a “...over 40 combined years of conference legacy resulting from the merger of two long-standing and successful previous conference excellence in Pathology Informatics series: APIII and Lab InfoTech Summit/AIMCL. All together, these two prior meetings, along with the instruction and scholarly exchange PI-Summit series, have offered over 40 combined years of excellence in Pathology Informatics instruction and for the pathology specialty.” scholarly exchange for the pathology specialty. Over these four decades, our specialty has witnessed a progressive succession from coverage of the Refreshment and lunch breaks will provide you with ample time to browse the exhibitor ballroom, fundamentals of computing and information technology, to increasingly sophisticated exemplars with displays by 23 exhibitors with IT-related products and services. This represents one of the where cogent use of information technology can be seen to greatly enhance both patient safety as largest assemblages of pathology informatics vendors available at any conference in the country. well and the diagnostic and predictive utility of the primary data generated by the collective fields We guarantee that you will gain a host of new ideas and solutions from all of these resources. of Anatomic Pathology and Laboratory Medicine. In consonance with the continuing evolution of the specialty, this year is particularly auspicious in that several watershed events—FDA clearance of All of the faculty PowerPoint lectures, along with synchronized audio, will be posted on the whole slide imaging for primary diagnosis, and the explosive growth in understanding of the utility conference website (PathologyInformatics.org) shortly after the conference adjournment.
    [Show full text]
  • Medical Videography Using a Mobile App: Retrospective Analysis
    JMIR MHEALTH AND UHEALTH Cambron et al Original Paper Medical Videography Using a Mobile App: Retrospective Analysis Julia C Cambron1, BS; Kirk D Wyatt2, MD; Christine M Lohse3, MS; Page Y Underwood4, JD; Thomas R Hellmich5, MD 1Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN, United States 2Division of Pediatric Hematology/Oncology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, United States 3Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, United States 4Legal Department, Mayo Clinic, Scottsdale, AZ, United States 5Department of Emergency Medicine, Mayo Clinic, Rochester, MN, United States Corresponding Author: Thomas R Hellmich, MD Department of Emergency Medicine Mayo Clinic 200 First Street Southwest Rochester, MN, 55905 United States Phone: 1 507 255 2216 Email: [email protected] Abstract Background: As mobile devices and apps grow in popularity, they are increasingly being used by health care providers to aid clinical care. At our institution, we developed and implemented a point-of-care clinical photography app that also permitted the capture of video recordings; however, the clinical findings it was used to capture and the outcomes that resulted following video recording were unclear. Objective: The study aimed to assess the use of a mobile clinical video recording app at our institution and its impact on clinical care. Methods: A single reviewer retrospectively reviewed video recordings captured between April 2016 and July 2017, associated metadata, and patient records. Results: We identified 362 video recordings that were eligible for inclusion. Most video recordings (54.1%; 190/351) were captured by attending physicians. Specialties recording a high number of video recordings included orthopedic surgery (33.7%; 122/362), neurology (21.3%; 77/362), and ophthalmology (15.2%; 55/362).
    [Show full text]
  • The Supreme Court's Myriad Effects on Scientific Research
    THE SUPREME COURT’S MYRIAD EFFECTS ON SCIENTIFIC RESEARCH: DEFINITIONAL FLUIDITY AND THE LEGAL CONSTRUCTION OF NATURE Peter Lee UC Davis School of Law Contents INTRODUCTION .................................................................................................................... 1 PART I. THE IMPACT ON MYRIAD GENETICS AND BRCA RESEARCH ............................... 3 PART II. UPSTREAM-DOWNSTREAM DYNAMICS IN PATENT LAW ..................................... 9 PART III. BROADER DOCTRINAL IMPLICATIONS ............................................................. 19 A. Elevating Patentable Subject Matter Doctrine to Police Patentability .................. 19 B. Creating a Strong and Flexible Exception for Nature from Patent Eligibility ...... 20 PART IV. ONGOING CHALLENGES AND LONG-TERM RAMIFICATIONS ............................ 28 CONCLUSION ...................................................................................................................... 31 INTRODUCTION Although patent law rarely captures the popular imagination, such was not the case in the summer of 2013. That June, the Supreme Court issued its much-anticipated decision in Association for Molecular Pathology v. Myriad Genetics.1 The decision culminated years of litigation over several patents held by Myriad Genetics, a Utah-based biotechnology company, covering two genes, BRCA 1 and BRCA 2. Mutations in these genes are correlated with a higher risk of developing breast and ovarian cancer. Based significantly on its patents, Myriad Genetics enjoyed exclusive
    [Show full text]
  • List of the Fellows and Members
    \ / ^' ^CVR C'i AN S- i .m vS^. fe# Itifos^ ^i^F^-SJffi" p MDCCCXX XI. A CATALOGUE OP THE FELLOWS, CANDIDATES, » AND . LICENTIATES, OP THE LONDON. PRINTEI> BY G. WOODFALL, ANGEL COURT, SKINNER STREET. /T^ o ^ A CATALOGUi: OF THE FELLOWS, CANDIDATES, AND LICENTIATES, OF THE 3aopal College of ^i)}mtinm, LONDON. FELLOWS. Sir Henry Halford, Bart. G.C.H. President, Physician to their Majesties, Curzon-street. Dr. Devereux Mytton, Garth. Dr. John Latham, Bradwall-HalU Cheshire. Dr. Thomas Monro. Dr. Wilham Moore, Isle of Wight. Dr. Edward Roberts, Elect, JB/oo?w56^^r^-S5'^^are. Dr. George Paulet Morris. Dr. Henry Ainslie, Dover-street. Dr. Paggen Wilham Mayo, Bridlington. Dr. Richard Powell. Dr. William Heberden, Fall Mall. Dr. Algernon Frampton, Elect, New Broad-st. Dr. George Williams, Oxford. Dr. Devey Fearon. Dr. Samuel Holland. Dr. Wilham George Maton, Elect, Physician Extraordinary to the King, New-street, Spring Gardens. Dr. James Franck, Hertford-street, Park-lane, Sir George Smith Gibbes, Knt. Bath. Dr. William Lambe, Elect, Kings-road, Bedford-row. 2 Dr. John Johnstone, Birmingham. Sir James Fellowes, Knt. Dr. Charles Price, Brighton. Dr. Thomas Turner, Elect, and Treasurer, Physician Extraordinary to the Queen, Cur- zon-street. Dr. Edward Nathaniel Bancroft, Jamaica, Dr. Charles Dalston Nevinson, Montague-square, Dr. Pelham Warren, Elect, Lower Brook-st, Dr. Robert Bree, Elect, George-street, Hanover-square Dr. John Cooke, Gower-street. Sir Arthur Brooke Faulkner, Knt. Cheltenham, Dr. Thomas Hume, Censor, South-street, Grosvenor-square Dr. Peter Rainier, Albany, Dr. Tristram Whitter. Dr. Clement Hue, Guildford-street. Dr. John Bright, Manchester-square, Dr.
    [Show full text]
  • Inhibition of Eif4e with Ribavirin Cooperates with Common Chemotherapies in Primary Acute Myeloid Leukemia Specimens
    Letters to the Editor 1197 Acknowledgements patient subgroup characterized by very poor prognosis. J Clin Oncol 1989; 7: 119–125. This study is supported in part by the grants CA 62242, CA 107476 3 San Miguel JF, Garcia-Sanz R, Gonzalez M, Moro MJ, Hernandez JM, and CA 62242 from the National Cancer Institute, National Ortega F et al. A new staging system for multiple myeloma based on the number of S-phase plasma cells. Blood 1995; 85: Institutes of Health, Bethesda, MD and the Eastern Cooperative 448–455. Oncology Group, Boston, MA (SVR). 4 Rajkumar SV, Fonseca R, Dewald GW, Therneau TM, Lacy MQ, Kyle RA et al. Cytogenetic abnormalities correlate with the plasma P Kapoor1, S Kumar1, SJ Mandrekar2, KM Laumann2, 1 1 1 1 cell labeling index and extent of bone marrow involvement in A Dispenzieri , MQ Lacy , D Dingli , MA Gertz , myeloma. Cancer Genet Cytogenet 1999; 113: 73–77. 1 1 1 1 RA Kyle , PR Greipp , SV Rajkumar and TE Witzig 5 Garcia-Sanz R, Gonzalez-Fraile MI, Mateo G, Hernandez JM, 1 Division of Hematology, Mayo Clinic, Lopez-Berges MC, de las Heras N et al. Proliferative activity of Rochester, MN, USA and plasma cells is the most relevant prognostic factor in elderly 2Division of Biomedical Statistics and Informatics, multiple myeloma patients. Int J Cancer 2004; 112: 884–889. Mayo Clinic, Rochester, MN, USA 6 Lacy MQ, Gertz MA, Dispenzieri A, Hayman SR, Geyer S, E-mail: [email protected] Kabat B et al. Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexametha- sone in newly diagnosed myeloma.
    [Show full text]
  • 2012 MVSS Historical Book
    Midwestern Vascular Surgical Society Historical Book THE MEDICAL COLLEGE OF WISCONSIN The Historical Book is dedicated to John R. Pfeifer, M.D., Historian Midwestern Vascular Surgical Society 2012 2012 MIDWESTERN VASCULAR SURGICAL SOCIETY TABLE OF Contents Page Executive Council/Committees ..................................................................3 Acknowledgments .....................................................................................7 Annual Meetings and Dates .......................................................................8 Presidents of the Midwestern Vascular Surgical Society ............................ 11 Names and Addresses of Presidents .......................................................... 87 Officers of the Society............................................................................. 88 History of the Midwestern Vascular Surgical Society ................................. 89 John R. Pfeifer Award ............................................................................ 106 Charles C. Guthrie Award ...................................................................... 107 The D. Emerick Szilagyi Award .............................................................. 113 Web Page History .................................................................................. 115 Distinguished Service Award ................................................................. 134 Constitution and By-Laws of the Society ................................................ 135 New Members Elected ..........................................................................
    [Show full text]
  • Characterization of a Pathogenic Variant in the ABCD1 Gene Through Protein Molecular Modeling
    Hindawi Case Reports in Genetics Volume 2020, Article ID 3256539, 7 pages https://doi.org/10.1155/2020/3256539 Case Report Characterization of a Pathogenic Variant in the ABCD1 Gene Through Protein Molecular Modeling John E. Richter Jr.,1 Charitha Vadlamudi,2 Sarah K. Macklin,1 Ayesha Samreen,3 Haytham Helmi,1 Daniel Broderick,4 Ahmed N. Mohammad,1 Stephanie L. Hines,5 Jay A. VanGerpen,6 Paldeep S. Atwal ,1 and Thomas R. Caulfield 1,7,8,9,10 1Department of Clinical Genomics, Mayo Clinic, Jacksonville, FL 32224, USA 2Department of Pulmonology, Mayo Clinic, Jacksonville, FL 32224, USA 3Department of Endocrinology, Mayo Clinic, Jacksonville, FL 32224, USA 4Department of Radiology, Mayo Clinic, Jacksonville, FL 32224, USA 5Department of Internal Medicine, Mayo Clinic, Jacksonville, FL 32224, USA 6Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA 7Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA 8Department of Cancer Biology, Mayo Clinic, Jacksonville, FL 32224, USA 9Department of Neurosurgery, Mayo Clinic, Jacksonville, FL 32224, USA 10Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL 32224, USA Correspondence should be addressed to omas R. Caulfield; caulfi[email protected] Received 15 August 2019; Accepted 19 November 2019; Published 25 January 2020 Academic Editor: Yoshiyuki Ban Copyright © 2020 John E. Richter Jr. et al. is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. e ATP-binding cassette, subfamily D, member 1 (ABCD1) protein is a peroxisomal half-transporter that allows for very long chain fatty acid (VLCFA) degradation.
    [Show full text]
  • Case Report Curing Opioid Toxicity with Intrathecal Targeted Drug Delivery
    Hindawi Case Reports in Medicine Volume 2019, Article ID 3428576, 6 pages https://doi.org/10.1155/2019/3428576 Case Report Curing Opioid Toxicity with Intrathecal Targeted Drug Delivery Thomas P. Pittelkow ,1,2 Markus A. Bendel ,1 Jacob J. Strand,2 and Susan M. Moeschler1 1Division of Pain Medicine, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine and Science, 200 First Street SW, Rochester, MN 55905, USA 2Center for Palliative Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, 200 First Street SW, Rochester, MN 55905, USA Correspondence should be addressed to omas P. Pittelkow; [email protected] Received 30 January 2019; Revised 16 April 2019; Accepted 2 May 2019; Published 16 May 2019 Academic Editor: Piotr K. Janicki Copyright © 2019 omas P. Pittelkow et al. is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Pain is one of the most feared symptoms that concern cancer patients and their families. Despite well-established guidelines set forth by the World Health Organization (WHO) on the treatment of cancer pain, nearly half of cancer patients report poorly controlled pain. One of the most serious side effects of systemic oral opioid use is neurotoxicity, which is characterized by altered mental status and systemic neurologic impairments. Treatment strategies are supportive in nature and focused on reducing or changing the offending opioid and correcting any metabolic deficiencies. Herein, we discuss a case of opioid-induced neuro- toxicity treated with intrathecal targeted drug delivery (TDD).
    [Show full text]